Overview

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Mal

Status:
Completed

Trial end date:
2014-11-01

Target enrollment:

Participant gender:

Summary

This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01 and to investigate the effect of food on the pharmacokinetics of DA-1229_01 in healthy male volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Dong-A ST Co., Ltd.

Treatments:

Metformin